- Home
- INM vs XWEL Comparison
INM vs XWEL Comparison
Compare INM & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- XWEL
- Stock Information
- Founded
- INM 1981
- XWEL 2006
- Country
- INM Canada
- XWEL United States
- Employees
- INM N/A
- XWEL N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- XWEL Other Consumer Services
- Sector
- INM Health Care
- XWEL Consumer Discretionary
- Exchange
- INM Nasdaq
- XWEL Nasdaq
- Market Cap
- INM 4.1M
- XWEL 4.8M
- IPO Year
- INM N/A
- XWEL N/A
- Fundamental
- Price
- INM $1.70
- XWEL $0.88
- Analyst Decision
- INM
- XWEL
- Analyst Count
- INM 0
- XWEL 0
- Target Price
- INM N/A
- XWEL N/A
- AVG Volume (30 Days)
- INM 61.5K
- XWEL 86.3K
- Earning Date
- INM 11-06-2025
- XWEL 11-14-2025
- Dividend Yield
- INM N/A
- XWEL N/A
- EPS Growth
- INM N/A
- XWEL N/A
- EPS
- INM N/A
- XWEL N/A
- Revenue
- INM $4,798,116.00
- XWEL $30,601,000.00
- Revenue This Year
- INM N/A
- XWEL N/A
- Revenue Next Year
- INM N/A
- XWEL N/A
- P/E Ratio
- INM N/A
- XWEL N/A
- Revenue Growth
- INM N/A
- XWEL N/A
- 52 Week Low
- INM $1.56
- XWEL $0.70
- 52 Week High
- INM $8.27
- XWEL $2.00
- Technical
- Relative Strength Index (RSI)
- INM 36.70
- XWEL 32.08
- Support Level
- INM $1.59
- XWEL $0.84
- Resistance Level
- INM $1.91
- XWEL $0.88
- Average True Range (ATR)
- INM 0.10
- XWEL 0.03
- MACD
- INM 0.00
- XWEL -0.00
- Stochastic Oscillator
- INM 29.47
- XWEL 5.28
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About XWEL XWELL Inc.
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers with premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.